Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
CALL
Xylem
XYL
$27.3B
| $205K | ﹤0.01% |
2,600
+900
| +53% | +$70K |
|
|
HTT
4927
CALL
High Templar Tech Ltd
HTT
$379M
| $204K | ﹤0.01% |
43,400
-13,400
| -24% | -$78.8K |
|
|
CNCE
4928
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $204K | ﹤0.01% |
22,107
+10,653
| +93% | +$75.5K |
|
|
BOCH
4929
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $204K | ﹤0.01% |
17,670
+8,877
| +101% | +$100K |
|
4930
American Superconductor
AMSC
$1.42B
| $203K | ﹤0.01% |
25,804
+12,839
| +99% | +$103K |
|
|
AKTS
4931
DELISTED
Akoustis Technologies Inc
AKTS
| $203K | ﹤0.01% |
25,436
+12,846
| +102% | +$100K |
|
|
CONN
4932
CALL
DELISTED
Conn's Inc.
CONN
| $203K | ﹤0.01% |
16,400
+11,300
| +222% | +$237K |
|
4933
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $202K | ﹤0.01% |
18,283
+6,864
| +60% | +$59.6K |
|
4934
Sutro Biopharma
STRO
$401M
| $202K | ﹤0.01% |
1,830
+557
| +44% | +$57.4K |
|
4935
Spyre Therapeutics
SYRE
$8.54B
| $202K | ﹤0.01% |
1,059
+514
| +94% | +$101K |
|
4936
PUT
Aurinia Pharmaceuticals
AUPH
$1.91B
| $201K | ﹤0.01% |
9,900
-132,600
| -93% | -$1.22M |
|
|
ONIT
4937
Onity Group
ONIT
$309M
| $201K | ﹤0.01% |
9,803
+4,726
| +93% | +$114K |
|
|
BPMP
4938
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $201K | ﹤0.01% |
12,864
+2,385
| +23% | +$35.4K |
|
|
CYOU
4939
CALL
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $201K | ﹤0.01% |
20,500
-1,600
| -7% | -$15.4K |
|
4940
Qfin Holdings
QFIN
$1.69B
| $200K | ﹤0.01% |
20,500
+9,500
| +86% | +$86K |
|
|
ITI
4941
DELISTED
Iteris, Inc.
ITI
| $200K | ﹤0.01% |
40,144
+19,978
| +99% | +$102K |
|
4942
ADT
ADT
$5.58B
| $199K | ﹤0.01% |
25,109
-41,216
| -62% | -$326K |
|
4943
PUT
AES
AES
$10.5B
| $199K | ﹤0.01% |
10,000
-1,000
| -9% | -$17.9K |
|
4944
Methanex
MEOH
$4.3B
| $199K | ﹤0.01% |
5,151
-39,766
| -89% | -$1.49M |
|
4945
InflaRx
IFRX
$250M
| $198K | ﹤0.01% |
50,000
| – | – |
|
4946
PUT
Prothena Corp
PRTA
$425M
| $198K | ﹤0.01% |
12,500
+12,000
| +2,400% | +$129K |
|
4947
CALL
Teradyne
TER
$57.6B
| $198K | ﹤0.01% |
2,900
-13,700
| -83% | -$870K |
|
|
SLCT
4948
DELISTED
Select Bancorp, Inc.
SLCT
| $198K | ﹤0.01% |
16,075
+7,722
| +92% | +$90.8K |
|
4949
Valmont Industries
VMI
$9.3B
| $197K | ﹤0.01% |
1,316
-8,444
| -87% | -$1.19M |
|
|
MIC
4950
CALL
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $197K | ﹤0.01% |
4,600
-25,800
| -85% | -$1.07M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.